Cue
Shang Hsuan Lin is an experienced scientist with a strong background in biomedical engineering and diagnostics. Currently serving as a Staff Scientist at Cue Health since March 2022, Shang Hsuan Lin has developed a microfluidic-based in vitro diagnostic (IVD) platform and optimized various molecular assays, including those for SARS-CoV-2. Prior experience includes a role as Senior Scientist at Wondfo USA, where several SARS-CoV-2 diagnostics projects were developed, and as a Scientist at Zepto Life Technology, focusing on immunoassays for cardiovascular diseases and SARS-CoV-2 using advanced GMR technology. Shang Hsuan Lin also held a Postdoctoral Research Associate position at the University of Minnesota, researching chemopreventive effects and drug resistance in leukemic cells. Educational qualifications include a Ph.D. in Biology from the University of Maryland, a Master’s in Bioengineering from Rice University, and a Bachelor’s in Biomedical Engineering and Environmental Sciences from National Tsing Hua University.
This person is not in any teams
This person is not in any offices
Cue
1 followers
Cue is on a mission is to create tools that empower physicians and consumers by increasing their access to actionable data. They are developing advanced technology and manufacturing to solve significant and important problems in healthcare. Headquartered in the Sorrento Valley area of San Diego, California, Cue is composed of multi-disciplinary engineering, regulatory, clinical, operations, production, and testing teams.